About Sanguine

Your committed partner for disease-state and healthy biospecimens

Read the Sanguine Brochure (opens in new tab, PDF) Leadership Team
A Sanguine study coordinator greeting a donor at her front door
Donor Community
70,000+
Diagnosed Conditions
100+
Projects Completed
2000+

Our Mission

Sanguine Biosciences is accelerating discovery through manufacturing for research in therapeutics and diagnostics by finding the biospecimens needed through our direct-to-donor model. We lower the barrier for people to participate in research by donor engagement and ease in participating - often collections occurring in the donor's home. For researchers, they receive high-quality biospecimens with comprehensive donor data.

Sanguine has been a trusted partner in translational, clinical, and cell and gene therapy research for many of the world's leading pharmaceutical and biotechnology companies. We have helped accelerate timelines and validate early-stage results, boosting confidence in advancing to clinical trials. Now, with our disease-state LeukoCore and GMP-grade healthy LeukoCert products, we are expanding our impact into process development and manufacturing.

"Our study coordinators are typically on a first name basis with the patients after the first call and maintain a really close relationship with them. It's that human-to-human contact many patients enjoy that helps them feel empowered and keeps them engaged."

Brian Neman
Brian Neman
CEO & CO-FOUNDER OF SANGUINE

History of Sanguine

  1. 2010

    Brian Neman and Gerald Lee founded Sanguine with one mobile phlebotomist and banking samples in a university lab

  2. 2012

    Online donor recruitment launched

  3. 2015

    Started collecting medical records along with the biospecimens

  4. 2017

    OnSite programs launched

  5. 2019

    Community Access launched

  6. 2022

    Leukopaks launched and San Diego lab opened

  7. 2023

    LeukoLotsâ„¢ launched

  8. 2024

    Triple ISO certification and LeukoCertâ„¢ launched

Leadership Team

  • Brian Neman, MHA

    Brian Neman, MHA

    CHIEF EXECUTIVE OFFICER

    Brian brings together a deep seated belief that empowering patients is the key to advancing medicine with a strong entrepreneurial drive. The result is Sanguine.

  • Gerald Lee

    Gerald Lee

    CHIEF OPERATIONS OFFICER

    Gerald has translated his experience leading a team studying Chronic Myeloid Leukemia (CML) at Stanford into the operational expertise that drives Sanguine's product development program.

  • Lisa AnnMarie Fleshman

    Lisa AnnMarie Fleshman

    SENIOR VICE PRESIDENT, QUALITY & CORPORATE OPERATIONS

    AnnMarie has spent the last decade of her career devoted to quality and compliance within the pharma industry, bringing high standards and innovative thought processes along with her.

  • Chelsea Caro

    VP OF SALES

Board of Directors

  • Brian Neman, MHA

    Brian Neman, MHA

    CHIEF EXECUTIVE OFFICER, SANGUINE BIOSCIENCES

  • Gerald Lee

    Gerald Lee

    CHIEF OPERATIONS OFFICER, SANGUINE BIOSCIENCES

  • Jeff Mayhew

    Jeff Mayhew

    CO-FOUNDER and CHIEF DEVELOPMENT OFFICER LabCONNECT

  • Marvin Yee, MBA

    Marvin Yee, MBA

    MANAGING PARTNER, CROWN FINANCIAL SERVICES

  • Cyrus K. Mirsaidi

    Cyrus K. Mirsaidi

    MANAGING PARTNER, BioSELECTIVE CAPITAL INVESTMENTS

Join Sanguine

Help us accelerate the pace of discovery and development by bridging the gap between patients and researchers.

Careers Opportunities